AI-designed drug shows promise for anti-aging and disease treatment
Genetic Engineering & Biotechnology News (GEN) - 21-Feb-2025Insilico’s ISM001-055 outperforms rapamycin in reducing inflammation and restoring cellular function
Join the club for FREE to access the whole archive and other member benefits.
Insilico’s ISM001-055 outperforms rapamycin in reducing inflammation and restoring cellular function
Pioneering treatments target underlying mechanisms of age-related diseases like pulmonary fibrosis
Drug improved chronic cough symptoms, contributing to a better quality of life\
Transforming respiratory care and reducing reliance on organ donors
Phase 2a trial results show positive outcomes among pulmonary fibrosis patients
Click on resource name for more details.
No blog posts found!